Kenya has set eyes on manufacturing HIV antiretroviral (ARV) drugs for both local and global consumption, pending approval from regulatory bodies.Director General for Health, Patrick Amoth, says the ...
Pfizer’s two-year run with the only 5-in-1 meningococcal vaccine on the U.S. market has come to an end. Now, GSK is ready to ...